Please try another search
SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome and Alzheimer’s disease and agitation; SCI-160 for the treatment of pain; SCI-210 for the treatment of autism spectrum disorder and status epilepticus; and CannAmide, an anti-inflammatory and chronic pain solution. The company has an agreement with Procaps to develop and commercially manufacture SCI-110 and CannAmide, a palmitoylethanolamide oral tablet in softgel capsule form. It also has an agreement with The Israeli Medical Center for Alzheimer’s to conduct a phase IIa clinical trial to evaluate the safety, tolerability, and efficacy of SCI-110 in patients with Alzheimer’s disease and agitation; and a collaboration with Clearmind Medicine Inc. The company was formerly known as Therapix Biosciences Ltd. and changed its name to SciSparc Ltd. in January 2021. SciSparc Ltd. was incorporated in 2004 and is headquartered in Tel Aviv-Yafo, Israel.
Name | Age | Since | Title |
---|---|---|---|
Avi Weizman | - | 2016 | Member of Scientific Advisory Board |
Kirsten Müller-Vahl | - | 2016 | Member of Scientific Advisory Board |
Joseph Tam | - | - | Member of Scientific Advisory Board |
Daniele Piomelli | - | - | Member of Scientific Advisory Board |
Mellar P. Davis | - | - | Member of Scientific Advisory Board |
Michael H. Bloch | - | 2016 | Member of Scientific Advisory Board |
Alon Dayan | 46 | 2021 | Independent Director |
Amitai Weiss | 62 | 2020 | Chairman of the Board |
Moshe Revach | 47 | 2020 | Independent Director |
Itschak Shrem | 77 | 2020 | President & Director |
Michael Davidson | 74 | 2016 | Member of Scientific Advisory Board |
Elon Eisenberg | - | - | Member of Scientific Advisory Board |
Lior Vider | 48 | 2020 | Independent Director |
Liat Sidi | 49 | 2020 | Independent Director |
Saoirse O'Sullivan | - | - | Member of Scientific Advisory Board |
Amnon Ben Shay | 60 | 2021 | Independent Director |
Avi Schroeder | - | - | Member of Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review